搜索临床试验以:REGN10933 REGN10987 combination therapy
总计425个结果
-
Regeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals终止
-
Regeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals终止
-
Regeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals完全的
-
Regeneron Pharmaceuticals终止
-
Regeneron Pharmaceuticals终止
-
Luye Pharma Group Ltd.Shang Dong Boan Biotechnology Co., Ltd (Co-sponsor)未知
-
Regeneron Pharmaceuticals终止
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials Group; SAb Biotherapeutics... 和其他合作者完全的
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdPeking University完全的
-
University of Western Ontario, CanadaPfizer完全的
-
Tongji HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital, China; Zhejiang University 和其他合作者招聘中
-
Immune-Onc TherapeuticsRegeneron Pharmaceuticals主动,不招人
-
Karyopharm Therapeutics Inc招聘中复发/难治性弥漫性大 B 细胞淋巴瘤美国, 西班牙, 以色列, 意大利, 波兰, 中国, 奥地利
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中转移性前列腺癌 | IV 期前列腺癌 AJCC v8 | 前列腺癌 | III 期前列腺癌 AJCC v8 | 晚期前列腺癌美国
-
Eun Jung KimMinistry of Health & Welfare, Korea未知
-
Hospital de Clinicas de Porto Alegre完全的Complication of CABG巴西
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.; Nanjing Geneseeq Technology Inc.招聘中
-
Alzheimer's Light LLC招聘中
-
NYU Langone HealthEli Lilly and Company; The Cleveland Clinic; Centocor, Inc.完全的
-
Miquel PujolInstitut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III终止